Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for plozasiran (Redemplo) for adult patients with genetically confirmed or clinically diagnosed familial chylomicronemia syndrome (FCS) for whom standard triglyceride lowering therapies have been inadequate.